Study Reveals Exciting Physician Growth in the Areas of Mobile, Social, and Online Access

Manhattan ResearchPhysicians show continued adoption of mobile and social media for professional purposes, as well as increasing dependency on digital resources at the point of care, according to pharmaceutical and healthcare market research company Manhattan Research's latest Taking the Pulse® study of over 2,000 U.S. physicians. The tenth version of this landmark research and strategic advisory service is focused on which technologies physicians have adopted, how they are currently using them, and how they plan to use them in the future. Taking the Pulse® v10.0 provides a rich data set with topical insights for pharma marketers, agencies, physician content and technology providers, and other parties interested in connecting with physicians.

"In 2010, the conversation has shifted away from whether physicians are online to understanding the degree to which digital content is changing the way physicians practice medicine," said Meredith Ressi, VP of research at Manhattan Research. "Professional use of smartphones and online user-generated content are no longer early adopter activities of a tech-savvy few – these types of activities are the norm for the majority of physicians today."

Key topics covered in the research include:

  • Online and Offline Professional Information Sources: Online and offline information sources used, including textbooks, journals, conferences, CME, reps, search engines, sites visited
  • Mobile Technology Adoption: Device adoption by platform (iPhone, BlackBerry, Palm, Android); professional activities conducted on the smartphone; top mobile apps and websites used
  • Online User-Generated Content: Use of physician-only communities, messageboards and blogs
  • General Access and Technology Profile: Practice technology profile; frequency of Internet use; frequency of professional activities online and offline
  • Patient Interaction and Education: Patients bringing information into office; sites recommended to patients; types of patient education sources of interest
  • Digital Health Infrastructure: Adoption of electronic medical records (EMR); electronic prescribing; impact of ARRA on decision to implement EMR system

Webinar April 29 - Register Today

Mrs. Ressi will host a complimentary webinar previewing the research topics covered in the Taking the Pulse® v10.0 study on Thursday, April 29 at 11am EST.

Register here: https://www2.gotomeeting.com/register/907415971

About Taking the Pulse®
Taking the Pulse® v10.0 is a market research and strategic advisory service focused on which technologies physicians have adopted, how they are currently using them, and how they plan to use them in the future. The study was conducted in Q1 2010 via online and offline survey methodology among a nationally representative sample of 2,033 U.S. practicing physicians. Broad physician market research can be segmented to provide insights for over twenty specialist groups. For additional product and subscription information, please visit http://www.manhattanresearch.com/ttp.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm and conducts annual research studies covering eHealth trends among physicians and consumers, including Taking the Pulse®, Taking the Pulse® Nurses, Taking the Pulse® Europe, Taking the Pulse® Asia, Cybercitizen Health®, Cybercitizen Health® Europe, ePharma Consumer®, and ePharma Physician®. Broad consumer and physician research is complemented by targeted analysis for over 100 consumer therapeutic segments and physician specialist segments. For more information, please visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.

Most Popular Now

AstraZeneca takes next steps towards broad and equ…

AstraZeneca has taken the next steps in its commitment to broad and equitable global access to the University of Oxford’s COVID-19 vaccine, following landmark agreements ...

Johnson & Johnson announces acceleration of it…

Johnson & Johnson (NYSE: JNJ) (the Company) today announced that through its Janssen Pharmaceutical Companies (Janssen) it has accelerated the initiation of the Phase 1/2...

Low-cost dexamethasone reduces death by up to one …

In March 2020, the RECOVERY (Randomised Evaluation of COVid-19 thERapY) trial was established as a randomised clinical trial to test a range of potential treatments for C...

Sanofi invests to make France its world class cent…

Sanofi detailed plans on how the Company will make significant investments in France to increase its vaccines research and production capacities, and contribute in respon...

Calquence showed promising clinical improvement in…

Results published in Science Immunology showed that Calquence (acalabrutinib), a Bruton’s tyrosine kinase (BTK) inhibitor, reduced markers of inflammation and improved cl...

Super-potent human antibodies protect against COVI…

A team led by Scripps Research has discovered antibodies in the blood of recovered COVID-19 patients that provide powerful protection against SARS-CoV-2, the coronavirus ...

New consortium EUbOPEN will provide tools to unloc…

Almost twenty years after deciphering the human genome, our understanding of human disease is still far from complete. One of the most powerful and versatile tools to bet...

AstraZeneca to supply Europe with up to 400 millio…

AstraZeneca has reached an agreement with Europe's Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400 milli...

Up to 45 percent of SARS-CoV-2 infections may be a…

An extraordinary percentage of people infected by the virus behind the ongoing deadly COVID-19 pandemic never show symptoms of the disease, according to the results of a ...

Researchers identify potent antibody cocktail to t…

Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail...

Gilead announces results from Phase 3 Trial of rem…

Gilead Sciences, Inc. (Nasdaq: GILD) announced topline results from the Phase 3 SIMPLE trial in hospitalized patients with moderate COVID-19 pneumonia. This open-label st...

Mayo finds convalescent plasma safe for diverse pa…

Mayo Clinic researchers and collaborators have found investigational convalescent plasma to be safe following transfusion in a diverse group of 20,000 patients. The findi...